Localization of 5-HT(1A) receptors in the living human brain using [Carbonyl-11C]WAY-100635: PET with anatomic standardization technique

Journal of Nuclear Medicine

Volumn 40, Issue 1, 1999, Pages 102-109

  Ito, Hiroshi ^a   Halldin, Christer ^b   Farde, Lars ^b  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^b NONE

Author keywords

Anatomic standardization; Brain; PET; Serotonin 5 HT(1A) receptor; WAY 100635

Indexed keywords

CARBON 11; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN ANTAGONIST; CARBON; DIAGNOSTIC AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN RECEPTOR;

ADULT; ANXIETY; ARTICLE; BRAIN SCINTISCANNING; DATA BASE; DEPRESSION; FUNCTIONAL ANATOMY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMAGE ANALYSIS; MALE; NEUROANATOMY; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOISOTOPE DISTRIBUTION; RECEPTOR DENSITY; SCHIZOPHRENIA; SEROTONIN RELEASE; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; SCINTISCANNING;

ADULT; BRAIN; CARBON RADIOISOTOPES; HUMANS; MALE; PIPERAZINES; PYRIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032587214     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Saxena PR. Serotonin receptors: subtypes, functional responses and therapeutic relevance. Pharmacol Ther. 1995;66:339-368.
2. 1A receptor antagonist, WAY-100635. Eur J Pharmacol. 1995;281: 81-88.
3. 1A receptor antagonist, to rat brain. J Neurochem. 1995;64:2716-2726.
4. 11C]WAY-100635, in monkey and human plasma by HPLC. Comparison of the behavior of an identified radioactive metabolite with parent radioligand in monkey using PET. Nucl Med Biol. 1996;23:627-634.
5. 1A receptors in human brain with PET and [carbonyl-C-11]WAY-100635. Eur J Pharmacol. 1996;301:R5-R7.
6. 11C]WAY-100635. Brain Res. 1997;745:96-108.
7. 1A receptor imaging in the human brain using [C-11]WAY-100635 and PET [Abstract]. J Nucl Med. 1997;38:286P.
8. Farde L, Ito H, Swahn CG, Pike VW, Halldin C. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. J Nucl Med. 1998;39:1965-1971.
9. Fox PT, Mintun MA, Reiman EM, Raichle ME. Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J Cereb Blood Flow Metab. 1988;8:642-653.
10. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ. The anatomy of melancholia: focal abnormalities of cerebral blood flow in major depression. Psychol Med. 1992;22:607-615.
11. Dolan RJ, Bench CJ, Brown RG, Scott LC, Friston KJ, Frackowiak RS. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry. 1992;55:768-773.
12. Ito H, Kawashima R, Awata S, et al. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med. 1996;37:410-414.
13. Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE. Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. J Cereb Blood Flow Metab. 1996;16:409-417.
14. Seitz RJ, Bohm C, Greitz T, et al. Accuracy and precision of the computerized brain atlas programme for localization and quantification in positron emission tomography. J Cereb Blood Flow Metab. 1990;10:443-457.
15. Greitz T, Bohm C, Holte S, Eriksson L. A computerized brain atlas: construction, anatomical content, and some applications. J Comput Assist Tomogr. 1991;15: 26-38.
16. 15O]butanol and positron emission tomography. J Cereb Blood Flow Metab. 1994;14:628-638.
17. Wienhard K, Dahlbom M, Eriksson L, et al. The ECAT EXACT HR: performance of a new high resolution position scanner. J Comput Assist Tomogr. 1994;18:110-118.
18. Watson CC, Newport D, Casey ME. A single scatter simulation technique for scatter correction in 3D PET. In: Grangeat P, Amans JL, eds. Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1996:255-268.
19. Bergstrom M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr. 1981;5:136-141.
20. Eriksson L, Holte S, Bohm C, Kesselberg M, Hovander B. Automatic blood sampling systems for positron emission tomography. IEEE Trans Nucl Sci. 1988;35:703-707.
21. 2-dopamine receptors studied by PET - a comparison to the equilibrium analysis. J Cereb Blood Flow Metab. 1989;9:696-708.
22. Halldin C, Swahn CG, Farde L, Sedvall G. Radioligand disposition and metabolism: key information in early drag development. In: Comer D, ed. PET for Drug Development and Evaluation. Dordrecht. The Netherlands: Kluwer Academic Publishers: 1995:55-65
23. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984;15:217-227.
24. Huang SC, Barrio JR, Phelps ME. Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches. J Cereb Blood Flow Metab. 1986;6:515-521.
25. Wong DF, Gjedde A, Wagner HN Jr. Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands. J Cereb Blood Flow Metab. 1986;6:137-146.
26. Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience. 1987;21:97-122.
27. 1A receptors in rat brain. Eur J Pharmacol. 1994;271:515-523.
28. 1A receptors with positron emission tomography. Life Sci. 1994;55:P1403-P1407.
29. 11C]WAY-100635. Eur J Pharmacol. 1995;283:R1-R3.
30. 11C]raclopride studies. J Cereb Blood Flow Metab. 1996;16:42-52.
31. Ito H, Iida H, Bloomfield PM, et al. Rapid calculation of regional cerebral blood flow and distribution volume using iodine-123-iodoamphetamine and dynamic SPECT. J Nucl Med. 1995;36:531-536.
32. Marquardt D. An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math. 1963;11:431-441.
33. 11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. J Cereb Blood Flow Metab. 1990;10:727-739.
34. Yamaguchi T, Kanno I, Uemura K, et al. Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke. 1986;17:1220-1228.
35. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age. Brain. 1990;113: 27-47.
36. 1A receptor antagonist. Brain Res. 1995;673: 217-225.
37. 18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab. 1993;13:24-42.
38. 2 dopamine receptor occupancy in the living human brain: a PET study with risperidone. Psychopharmacology. 1993;110:265-272.
39. Vita A, Bressi S, Perani D, et al. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. Am J Psychiatry. 1995;152:876-882.
40. 1B recognition sites. Brain Res. 1986;376:85-96.
41. 1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res. 1991;554:56-64.